<DOC>
	<DOCNO>NCT00221416</DOCNO>
	<brief_summary>This investigator-initiated study whose primary aim determine effectiveness aripiprazole ( AbilifyÂ® ) help person symptom mania whose current medication completely control symptom . Aripiprazole medication approve United States Food Drug Administration ( FDA ) treatment Schizophrenia . A secondary aim research explore whether CYP 2D6 polymorphism related side effect aripiprazole . The goal research identify individual metabolize aripiprazole rapidly slowly , potentially help clinician make dose adjustment decrease risk adverse event .</brief_summary>
	<brief_title>An Open-Label Trial Aripiprazole Children Adolescents With Bipolar Disorder</brief_title>
	<detailed_description>The primary aim study ass effectiveness , safety , tolerability aripiprazole treatment child adolescent bipolar disorder . The secondary aim study determine common polymorphic variation CYP 2D6 gene underlie inter-individual variability aripiprazole systemic drug exposure occurrence treatment emergent side effect .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>1 . Male Females ; age 7 year 0 month 17 year 12 month 2 . Bipolar I Disorder , mixed manic episode , psychotic nonpsychotic , accord DSM IV criterion . 3 . Score &gt; 20 YMRS baseline . 4 . Ability willingness provide assent inform write consent least one parent legal guardian 5 . No current general medical illness require medication would effect interpretation study outcome . 6 . Subjects must least normal intelligence . 7 . Female patient childbearing potential must use reliable method contraception , e.g . hormonal contraceptive , DepoProvera , doublebarrier method ( e.g . condom diaphragm , condom foam , condom sponge ) abstinence ) . Females childbearing potential must negative serum pregnancy test immediately prior study entry . 8 . Must able swallow oral medication ( tablet ) . 1 . A current lifetime DSMIV diagnosis schizophrenia , autistic disorder , schizoaffective disorder , pervasive developmental disorder , obsessive compulsive disorder 2 . Known IQ &lt; 70 3 . Patients high suicide risk define serious suicide attempt require medical intervention current suicide risk safely manage determined clinical judgment investigator . 4 . Concurrent cognitive behavioral psychotherapy . 5 . Present past ( within 3 month ) DSMIV diagnosis substance abuse/dependence . 6 . Female patient pregnant , try become pregnant , nursing infant , use reliable form contraception . 7 . Bipolar subject currently stable mood stabilizer atypical neuroleptic . 8 . Patient fail previous adequate course aripiprazole . 9 . A known hypersensitivity aripiprazole component . 10 . Participated investigational drug/device trial within last 30 day . 11 . Patients severe renal insufficiency , define creatinine clearance &lt; 30ml/min . history lab finding .</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>child</keyword>
	<keyword>adolescent</keyword>
</DOC>